{"version":"1.0","provider_name":"France Angels","provider_url":"https:\/\/www.franceangels.org\/en\/","author_name":"sylvain Godard","author_url":"https:\/\/www.franceangels.org\/en\/article\/author\/sylvainfranceangels-org\/","title":"Alsace Business Angels et Yeast soutiennent ALBUPAD - France Angels","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"u3WJnz7bgy\"><a href=\"https:\/\/www.franceangels.org\/en\/article\/alsace-business-angels-et-yeast-soutiennent-albupad\/\">Alsace Business Angels et Yeast soutiennent ALBUPAD<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.franceangels.org\/en\/article\/alsace-business-angels-et-yeast-soutiennent-albupad\/embed\/#?secret=u3WJnz7bgy\" width=\"600\" height=\"338\" title=\"&#8220;Alsace Business Angels et Yeast soutiennent ALBUPAD&#8221; &#8212; France Angels\" data-secret=\"u3WJnz7bgy\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2026\/03\/Visuel-levee-de-fonds-Albupad-1024x505.png","thumbnail_width":1024,"thumbnail_height":505,"description":"ALBUPAD s\u00e9curise 1,3 M\u20ac aupr\u00e8s d\u2019Alsace Business Angels, Yeast et de Bpifrance pour d\u00e9velopper sa technologie de lib\u00e9ration prolong\u00e9e au service des th\u00e9rapies innovantes. Fond\u00e9e en 2024 par\u00a0Eya Aloui\u00a0et\u00a0Jordan Beurton, la startup deeptech\u00a0d\u00e9veloppe une plateforme brevet\u00e9e\u00a0de biomat\u00e9riaux \u00e0 base d\u2019albumine r\u00e9volutionnant la prise en charge des patients atteints de maladies chroniques et de cancers gr\u00e2ce&hellip;"}